Market research
PGHH.NSE Procter & Gamble Hygiene and Health Care Limited
NSE INR Consumer Defensive
Latest close
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 244B
- P/E ratio
- 31.15
- Analyst target
- 10834
- Dividend yield
- 0.0%
- Beta
- 0.21
Profile
Company facts
- Exchange
- NSE
- Currency
- INR
- Sector
- Consumer Defensive
- Industry
- Household & Personal Products
- ISIN
- INE179A01014
- Market cap
- 244B
- P/E ratio
- 31.15
- Analyst target
- 10834
- Dividend yield
- 0.0%
- Beta
- 0.21
About
About Procter & Gamble Hygiene and Health Care Limited
Procter & Gamble Hygiene and Health Care Limited manufactures and sells branded packaged fast-moving consumer goods in the feminine care and healthcare businesses in India and internationally. It operates through Health care Products and Hygiene Products segments. The company offers health care products, including ointments and creams, cough drops, and tablets; and hygiene products, such as feminine hygiene and other skin care hygiene products, as well as feminine care pads. It also provides baby care products comprising nappies, pants, and baby wipes; grooming products; laundry products; hair care products; home, personal and skin care, and oral products. The company sells its products under the Vicks, Whisper, Pampers, Ariel, Tide, Gillette, Head & Shoulders, Herbal Essences, Pantene, Ambi Pur, Oral-B, Olay, and Old Spice brands through mass merchandisers, as well as grocery, membership club, drug, department, and high frequency stores. The company was incorporated in 1964 and is based in Mumbai, India. Procter & Gamble Hygiene and Health Care Limited operates as a subsidiary of The Procter & Gamble Company.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the PGHH.NSE discussion.
5 years, 5 months ago
Procter & Gamble Hygiene and Health Care Limited is currently in a long term uptrend where the price is trading 10.8% above its 200 day moving average.
From a valuation standpoint, the stock is 257.3% more expensive than other stocks from the Consumer Defensive sector with a price to sales ratio of 12.3.
Procter & Gamble Hygiene and Health Care Limited's total revenue rose by 18.5% to $10B since the same quarter in the previous year.
Its net income has increased by 84.4% to $3B since the same quarter in the previous year.
Finally, its free cash flow grew by 133.1% to $7B since the same quarter in the previous year.
Based on the above factors, Procter & Gamble Hygiene and Health Care Limited gets an overall score of 4/5.